Bavarian Biotech Report 2011/2012 (7MB) - Bio M

Haupt Pharma Sales GmbHCMOKeywords: Full service contract development and manufacturing, Clinical TrailSupply Services, Cytotoxics, Hormones, high potent APIsWith nine production sites in Germany, France, Italy and Japan and a representativeoffice in the USA, Haupt Pharma is one of the leading contractdevelopers and manufacturers in Europe. With our full service, which coverspharmaceutical development, materials procurement, commercial production,packaging and distribution, we will manage important sections of yourvalue chain. Haupt Pharma provides a technology that covers most pharmaceuticaldosage forms, with a special expertise in sterile products and lyophilizedformulations. In addition to conventional APIs, we handle cytostatics,hormones, beta-lactam antibiotics and controlled drugs. Apart frompharmaceuticals (ethical and OTC), our portfolio includes veterinary medicinalproducts, dietary supplements and cosmetics. We serve regulated marketsworldwide, with a particular focus on Europe, USA and Japan. Morethan 200 customers, among them many global players, rely on HauptPharma's manufacturing, development and clinical trial supply services.Contact:Christian SchmittPfaffenrieder Str. 5-7D-82515 WolfratshausenPhone: +49 (0) 8171 414 150Fax: +49 (0) 8171 414 109E-Mail:Christian.Schmitt@haupt-pharma.deInternet: www.haupt-pharma.deHematris Wound Care GmbHMEDTECHKeywords: DevicesHematris Wound Care GmbH develops, manufactures and markets productsin the area of wound care. Our major initial focus is the marketing of hemostaticproducts to control bleeding.We are experts in the field of hemostasis and wound healing. Our vision isto build up an attractive company together with our investors in this businessarea.Contact:Dr. Dr. Stefan BertschProfessor-Messerschmitt-Str. 3D-85579 NeubibergPhone: +49 (0) 89 6008761-0Fax: +49 (0) 89 6008761-24E-Mail: bertsch@hematris.deInternet: www.hematris.deHepa Wash GmbHMEDTECHKeywords: Hepatology, DevicesThe Hepa Wash GmbH is a medical device company developing a new liverassist device for the treatment of patient with life-threatening liver disease.Main features of Hepa Washs extracorporeal technology are its highlyefficiency albumin-dialysis and its innovative albumin regeneration circuit.Hepa Wash is dedicated to developing a therapy that is several times moreeffective than currently available treatments and to significantly increase thesurvival rate and quality of live of patients with life-threatening liver disease.Contact:PD Dr. Bernhard KreymannAgnes-Pockels-Bogen 1D-80992 MünchenPhone: +49 (0) 89 4111842-0Fax: +49 (0) 89 4111842-09Internet: www.hepawash.com69